Title : Plasma B-type natriuretic peptide reduction predicts long-term response to levosimendan therapy in acutely decompensated chronic heart failure.

Pub. Date : 2010 Feb 18

PMID : 18973957






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Plasma B-type natriuretic peptide reduction predicts long-term response to levosimendan therapy in acutely decompensated chronic heart failure. Simendan natriuretic peptide B Homo sapiens
2 In the levosimendan group, treatment-induced percent BNP change was the best predictor of events (OR=0.970, 95% CI=0.954-0.986, p<0.001). Simendan natriuretic peptide B Homo sapiens
3 CONCLUSION: Treatment-induced BNP reduction is an independent predictor of 6-month outcome following levosimendan therapy in ADHF. Simendan natriuretic peptide B Homo sapiens